Demars Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,020
Closed -$204K 77
2022
Q1
$204K Sell
2,020
-20
-1% -$2.1K 0.1% 86
2021
Q4
$210K Sell
2,040
-620
-23% -$57.3K 0.11% 88
2021
Q3
$226K Sell
2,660
-3,915
-60% -$328K 0.13% 82
2021
Q2
$549K Buy
6,575
+20
+0.3% +$1.64K 0.33% 51
2021
Q1
$493K Sell
6,555
-60
-0.9% -$4.37K 0.33% 52
2020
Q4
$452K Buy
6,615
+5
+0.1% +$325 0.32% 50
2020
Q3
$386K Buy
6,610
+1,479
+29% +$92K 0.29% 46
2020
Q2
$333K Buy
5,131
+461
+10% +$29K 0.28% 46
2020
Q1
$277K Buy
+4,670
New +$312K 0.29% 42

Other funds holding CVS

Demars Financial Group's CVS Position: Q2 2022 in Review

Demars Financial Group sold out of CVS Health (CVS) in Q2 2022, closing a stake of 2,020 shares — an estimated $204K sold.

Demars Financial Group first reported a position in CVS in Q1 2020 and held it in 9 quarters. The position peaked at $549K in Q2 2021. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Demars Financial Group reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
  • Demars Financial Group sold 2,020 CVS Health shares in Q2 2022, an estimated $204K.
  • Demars Financial Group first reported a position in CVS Health in Q1 2020 and held it in 9 quarters.
  • Demars Financial Group's CVS Health position peaked at $549K in Q2 2021.
  • 2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Demars Financial Group's 13F filing for Q2 2022, filed 22 Jul 2022.